Detail of GM0017
Summary
The genetically modified enzybiotic, named CSCD , constructed by Domains Assembly strategy, keep the lytic activity.With CSCD
Sequence Length: 328 AA.
Mass: 36089.7 Da.
Isoelectric Point: 8.5
Function: exhibit lytic activity against cells of C. sporogenes
Construction
GM0017, constructed by Domains Assembly strategy. No schema construted on GM0017
Details:
GM0017[1-177]: derive from protein I1TJX3 sequence 1-177
I1TJX3, 264 AA., the Endolysin CS74L from Clostridium phage phi8074-B1
Source: Clostridium phage phi8074-B1
Molecular Function: 0008745, the N-acetylmuramoyl-L-alanine amidase activity?
Linking to UniprotKB
Linging to InterPro
Domains and repeats
2-167: IPR002508, the Cell wall hydrolase/autolysin, catalyticGO term prediction
Biological Process: 0009253, the peptidoglycan catabolic processMolecular Function: 0008745, the N-acetylmuramoyl-L-alanine amidase activity?
Linking to UniprotKB
Linging to InterPro
GM0017[178-267]: derive from protein T4YXV2 sequence 180-270
T4YXV2, 270 AA., the N-acetylmuramoyl-L-alanine amidase family protein from Clostridium difficile CD92
Source: Clostridium difficile CD92
Molecular Function: 0008745, the N-acetylmuramoyl-L-alanine amidase activity?
Linking to UniprotKB
Linging to InterPro
Domains and repeats
1-175: IPR002508, the Cell wall hydrolase/autolysin, catalyticGO term prediction
Biological Process: 0009253, the peptidoglycan catabolic processMolecular Function: 0008745, the N-acetylmuramoyl-L-alanine amidase activity?
Linking to UniprotKB
Linging to InterPro
Annotation
1-177
178-267
1-177
: EAD, Amidase domain, derived from Lytic bacteriophage ATCC 8074-B1 endolysin CS74L;178-267
: CBD, Cell wall-targeting domain, derived from Clostridium difficile bacteriophage CD27 endolysin CD27L;Domain and repeats:
2-167
: IPR002508,Cell wall hydrolase/autolysin, catalytic; GO term prediction:
0008745, the N-acetylmuramoyl-L-alanine amidase activity
0009253, the peptidoglycan catabolic process
MKIGIDMGHTLSGADYGVVGLRPESVLTREVGTKVIYKLQKLGHVVVNCTVDKASSVSESLYTRYYRANQANVDLFISIHFNATPGGTGTEVYTYAGRQLGEATRIRQEFKSLGLRDRGTKDGSGLAVIRNTKAKAMLVECCFCDNPNDMKLYNSESFSNAIVKGITGKLPNGESGNNNQGGNKVKAVVIYNEGADRRGAEYLADYLNCPTISNSRTFDYSCVEHVYAVGGKKEQYT-NEGVKQMYKHTIVYDGEVDKISATVVGWGYNDGKILICDIKDYVPGQTQNLYVVGGGACEKISSITKEKFIMIKGNDRFDTLYKALDFINR